Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies.

Ataie-Kachoie P, Pillai K, Badar S, Akhter J, Morris DL.

Am J Cancer Res. 2018 Oct 1;8(10):2064-2075. eCollection 2018.

2.

Estimation of the Direct Cost of Poliomyelitis Rehabilitation Treatment to Pakistani Patients: A 53-Year Retrospective Study.

Naqvi AA, Naqvi SBS, Zehra F, Verma AK, Usmani S, Badar S, Ahmad R, Ahmad N.

Appl Health Econ Health Policy. 2018 Aug 21. doi: 10.1007/s40258-018-0422-6. [Epub ahead of print]

PMID:
30128833
3.

Awareness, knowledge and attitude towards breast cancer, breast screening and early detection techniques among women in Pakistan.

Naqvi AA, Zehra F, Ahmad R, Ahmad R, Ahmad N, Yazdani N, Usmani S, Younus I, Badar S, Khan SJ.

J Pak Med Assoc. 2018 Apr;68(4):576-586.

4.

Performance of the Xpert HIV-1 Viral Load Assay: a Systematic Review and Meta-analysis.

Nash M, Huddart S, Badar S, Baliga S, Saravu K, Pai M.

J Clin Microbiol. 2018 Mar 26;56(4). pii: e01673-17. doi: 10.1128/JCM.01673-17. Print 2018 Apr.

5.

Identification of new BMP6 pro-peptide mutations in patients with iron overload.

Piubelli C, Castagna A, Marchi G, Rizzi M, Busti F, Badar S, Marchetti M, De Gobbi M, Roetto A, Xumerle L, Suku E, Giorgetti A, Delledonne M, Olivieri O, Girelli D.

Am J Hematol. 2017 Jun;92(6):562-568. doi: 10.1002/ajh.24730. Epub 2017 Apr 29.

6.

Age estimation of a sample of Pakistani population using Coronal Pulp Cavity Index in molars and premolars on Orthopantomogram.

Badar SB, Ghafoor R, Khan FR, Hameed MH.

J Pak Med Assoc. 2016 Oct;66(Suppl 3)(10):S39-S41.

PMID:
27895350
7.

Prevalence of musculoskeletal disorders among dentists in teaching hospitals in Karachi, Pakistan.

Hameed MH, Ghafoor R, Khan FR, Badar SB.

J Pak Med Assoc. 2016 Oct;66(Suppl 3)(10):S36-S38.

PMID:
27895349
8.

Incidence and Clinical Outcome of Patients with Hypertensive Acute Ischemic Stroke: An Update from Tertiary Care Center of Central India.

Nayak AR, Shekhawat SD, Lande NH, Kawle AP, Kabra DP, Chandak NH, Badar SR, Raje DV, Daginawala HF, Singh LR, Kashyap RS.

Basic Clin Neurosci. 2016 Oct;7(4):351-360.

9.

Prediction of Outcome in Diabetic Acute Ischemic Stroke Patients: A Hospital-Based Pilot Study Report.

Nayak AR, Badar SR, Lande N, Kawle AP, Kabra DP, Chandak NH, Raje DV, Singh LR, Daginawala HF, Kashyap RS.

Ann Neurosci. 2016 Oct;23(4):199-208. Epub 2016 Oct 4.

10.

Occupational Asthma: Contribution of Smoking and Hereditary Effects.

Badar S, Ahmed SW, Mahmood ZA, Khaliq SA, Azhar I, Younus I.

Iran J Public Health. 2016 Jul;45(7):956-7. No abstract available.

11.

Diagnostic perplexity of panoramic radiograph.

Badar SB, Ghafoor R.

BMJ Case Rep. 2016 Jul 15;2016. pii: bcr2016216353. doi: 10.1136/bcr-2016-216353. No abstract available.

12.

Evaluation of antiviral activity of plant extracts against foot and mouth disease virus in vitro.

Younus I, Siddiq A, Ishaq H, Anwer L, Badar S, Ashraf M.

Pak J Pharm Sci. 2016 Jul;29(4):1263-8.

PMID:
27393440
13.

Detection of a rare mutation in the ferroportin gene through targeted next generation sequencing.

Ferbo L, Manzini PM, Badar S, Campostrini N, Ferrarini A, Delledonne M, Francisci T, Tassi V, Valfrè A, Dall'omo AM, D'antico S, Girelli D, Roetto A, De Gobbi M.

Blood Transfus. 2016 Nov;14(6):531-534. doi: 10.2450/2016.0286-15. Epub 2016 Apr 28. No abstract available.

14.

Identification of novel mutations in hemochromatosis genes by targeted next generation sequencing in Italian patients with unexplained iron overload.

Badar S, Busti F, Ferrarini A, Xumerle L, Bozzini P, Capelli P, Pozzi-Mucelli R, Campostrini N, De Matteis G, Marin Vargas S, Giorgetti A, Delledonne M, Olivieri O, Girelli D.

Am J Hematol. 2016 Jun;91(4):420-5. doi: 10.1002/ajh.24304.

15.

Comparative evaluation of risk factors, outcome and biomarker levels in young and old acute ischemic stroke patients.

Kawle AP, Nayak AR, Lande NH, Kabra DP, Chandak NH, Badar SR, Raje DV, Taori GM, Daginawala HF, Kashyap RS.

Ann Neurosci. 2015 Apr;22(2):70-7. doi: 10.5214/ans.0972.7531.220204.

16.
17.

Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangements.

Egan JB, Barrett MT, Champion MD, Middha S, Lenkiewicz E, Evers L, Francis P, Schmidt J, Shi CX, Van Wier S, Badar S, Ahmann G, Kortuem KM, Boczek NJ, Fonseca R, Craig DW, Carpten JD, Borad MJ, Stewart AK.

PLoS One. 2014 Feb 5;9(2):e87113. doi: 10.1371/journal.pone.0087113. eCollection 2014.

18.

Minocycline targets the NF-κB Nexus through suppression of TGF-β1-TAK1-IκB signaling in ovarian cancer.

Ataie-Kachoie P, Badar S, Morris DL, Pourgholami MH.

Mol Cancer Res. 2013 Oct;11(10):1279-91. doi: 10.1158/1541-7786.MCR-13-0239. Epub 2013 Jul 15.

19.

Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice.

Henning JR, Graffeo CS, Rehman A, Fallon NC, Zambirinis CP, Ochi A, Barilla R, Jamal M, Deutsch M, Greco S, Ego-Osuala M, Bin-Saeed U, Rao RS, Badar S, Quesada JP, Acehan D, Miller G.

Hepatology. 2013 Aug;58(2):589-602. doi: 10.1002/hep.26267. Epub 2013 Jun 24.

20.

Minocycline inhibits malignant ascites of ovarian cancer through targeting multiple signaling pathways.

Pourgholami MH, Ataie-Kachoie P, Badar S, Morris DL.

Gynecol Oncol. 2013 Apr;129(1):113-9. doi: 10.1016/j.ygyno.2012.12.031. Epub 2012 Dec 26.

PMID:
23274564
21.

MyD88 inhibition amplifies dendritic cell capacity to promote pancreatic carcinogenesis via Th2 cells.

Ochi A, Nguyen AH, Bedrosian AS, Mushlin HM, Zarbakhsh S, Barilla R, Zambirinis CP, Fallon NC, Rehman A, Pylayeva-Gupta Y, Badar S, Hajdu CH, Frey AB, Bar-Sagi D, Miller G.

J Exp Med. 2012 Aug 27;209(9):1671-87. doi: 10.1084/jem.20111706. Epub 2012 Aug 20.

22.

Dendritic cell populations with different concentrations of lipid regulate tolerance and immunity in mouse and human liver.

Ibrahim J, Nguyen AH, Rehman A, Ochi A, Jamal M, Graffeo CS, Henning JR, Zambirinis CP, Fallon NC, Barilla R, Badar S, Mitchell A, Rao RS, Acehan D, Frey AB, Miller G.

Gastroenterology. 2012 Oct;143(4):1061-72. doi: 10.1053/j.gastro.2012.06.003. Epub 2012 Jun 12.

23.

Association of hepatitis C virus with insulin resistance: evidences from animal studies and clinical studies.

Badar S, Khubaib B, Idrees M, Hussain A, Awan Z, Butt S, Afzal S, Akram M, Fatima Z, Aftab M, Saleem S, Munir S, Rauff B, Naudhani M, Ali L, Ali M, Rehman I.

Hepat Mon. 2012 Jan;12(1):11-5. Epub 2012 Jan 20.

24.

Minocycline inhibits growth of epithelial ovarian cancer.

Pourgholami MH, Mekkawy AH, Badar S, Morris DL.

Gynecol Oncol. 2012 May;125(2):433-40. doi: 10.1016/j.ygyno.2012.01.006. Epub 2012 Jan 16.

PMID:
22252097
25.

Serotype and genotype analysis of dengue virus by sequencing followed by phylogenetic analysis using samples from three mini outbreaks-2007-2009 in Pakistan.

Fatima Z, Idrees M, Bajwa MA, Tahir Z, Ullah O, Zia MQ, Hussain A, Akram M, Khubaib B, Afzal S, Munir S, Saleem S, Rauff B, Badar S, Naudhani M, Butt S, Aftab M, Ali L, Ali M.

BMC Microbiol. 2011 Sep 10;11:200. doi: 10.1186/1471-2180-11-200.

26.

Characterization of hepatitis C Virus genotype 3a hypervariable region 1 in patients achieved rapid virological response to alpha interferon and ribavirin combination therapy.

Akram M, Idrees M, Hussain A, Afzal S, Ilyas M, Zafar S, Aftab M, Badar S, Khubaib B.

Virol J. 2011 May 23;8:253. doi: 10.1186/1743-422X-8-253.

27.

A situational analysis of HIV and AIDS in Pakistan.

Ilyas M, Asad S, Ali L, Shah M, Badar S, Sarwar MT, Sumrin A.

Virol J. 2011 Apr 25;8:191. doi: 10.1186/1743-422X-8-191. Review.

28.

An overview of treatment response rates to various anti-viral drugs in Pakistani hepatitis B virus infected patients.

Ali L, Idrees M, Ali M, Rehman IU, Hussain A, Afzal S, Butt S, Saleem S, Munir S, Badar S.

Virol J. 2011 Jan 15;8:20. doi: 10.1186/1743-422X-8-20. Review.

29.

Mutations in the E2-PePHD region of hepatitis C virus genotype-3a and correlation with response to interferon and ribavirin combination therapy in Pakistani patients.

Afzal S, Idrees M, Akram M, Awan Z, Khubaib B, Aftab M, Fatima Z, Badar S, Hussain A.

Virol J. 2010 Dec 31;7:377. doi: 10.1186/1743-422X-7-377.

30.

Hepatitis C treatment: current and future perspectives.

Munir S, Saleem S, Idrees M, Tariq A, Butt S, Rauff B, Hussain A, Badar S, Naudhani M, Fatima Z, Ali M, Ali L, Akram M, Aftab M, Khubaib B, Awan Z.

Virol J. 2010 Nov 1;7:296. doi: 10.1186/1743-422X-7-296. Review.

31.

Albendazole inhibits endothelial cell migration, tube formation, vasopermeability, VEGF receptor-2 expression and suppresses retinal neovascularization in ROP model of angiogenesis.

Pourgholami MH, Khachigian LM, Fahmy RG, Badar S, Wang L, Chu SW, Morris DL.

Biochem Biophys Res Commun. 2010 Jul 9;397(4):729-34. doi: 10.1016/j.bbrc.2010.06.019. Epub 2010 Jun 9.

PMID:
20537982
32.

Continuous versus interrupted technique of ventricular septal defect (VSD) closure in total correction for tetrology of Fallot pertaining to residal VSD.

Tanveer R, Khan AU, Siddiqi TA, Siddique S, Nasreen A, Salman-ur-Rehman, Badar S.

J Pak Med Assoc. 2010 Apr;60(4):253-6.

33.

Potent inhibition of tumoral hypoxia-inducible factor 1alpha by albendazole.

Pourgholami MH, Cai ZY, Badar S, Wangoo K, Poruchynsky MS, Morris DL.

BMC Cancer. 2010 Apr 15;10:143. doi: 10.1186/1471-2407-10-143.

34.
35.

Inhibition of cell proliferation, vascular endothelial growth factor and tumor growth by albendazole.

Pourgholami MH, Cai ZY, Wang L, Badar S, Links M, Morris DL.

Cancer Invest. 2009 Feb;27(2):171-7. doi: 10.1080/07357900802210752.

PMID:
19235589
36.

Massive retroperitoneal pseudotumour in a patient with type 3 von Willebrand disease.

Eby CS, Caracioni AA, Badar S, Joist JH.

Haemophilia. 2002 Mar;8(2):136-41.

PMID:
11952849
37.

Mechanisms of Ca2+ antagonism in imipramine-induced toxicity of isolated adult rat cardiomyocytes.

Watts JA, Yates KM, Badar SK, Marcengill MB, Kline JA.

Toxicol Appl Pharmacol. 1998 Nov;153(1):95-101.

PMID:
9875303

Supplemental Content

Support Center